Non-small cell lung cancer recurrence following surgery and perioperative chemotherapy: Comparison of two chemotherapy regimens (IFCT-0702: A randomized phase 3 final results study)-Reference-Cited by-同舟云学术

Non-small cell lung cancer recurrence following surgery and perioperative chemotherapy: Comparison of two chemotherapy regimens (IFCT-0702: A randomized phase 3 final results study)

Published:2015-08 Issue:2 Volume:89 Page:139-145
ISSN:0169-5002
Container-title:Lung Cancer
language:en
Short-container-title:Lung Cancer

Author:

Moro-Sibilot Denis,Audigier-Valette Clarisse,Merle Patrick,Quoix Elisabeth,Souquet Pierre-Jean,Barlesi Fabrice,Chouaid Christos,Molinier Olivier,Bennouna Jaafar,Lavolé Armelle,Mazières Julien,Toffart Anne-Claire,Langlais Alexandra,Morin Franck,Zalcman Gérard

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference25 articles.

1. Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small-cell lung cancer;Arriagada;N Engl J Med,2004

2. Adjuvant vinorelbine plus cisplatin versus observation in patients with completely resected stage IB-IIIA non-small-cell lung cancer (Adjuvant Navelbine International Trialist Association [ANITA]): a randomised controlled trial;Douillard;Lancet Oncol,2006

3. Lung adjuvant cisplatin evaluation: a pooled analysis by the LACE collaborative group;Pignon;J Clin Oncol,2008

4. Adjuvant paclitaxel plus carboplatin compared with observation in stage IB non-small-cell lung cancer: CALGB 9633 with the cancer and leukemia group B, radiation therapy oncology group, and north central cancer treatment group study groups;Strauss;J Clin Oncol,2008

5. Randomized phase III trial of vinorelbine plus cisplatin compared with observation in completely resected stage IB and II non-small-cell lung cancer: updated survival analysis of JBR-10;Butts;J Clin Oncol,2010

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Metabolic Reprogramming Driven by IGF2BP3 Promotes Acquired Resistance to EGFR Inhibitors in Non–Small Cell Lung Cancer;Cancer Research;2023-04-16

2. Cisplatin versus carboplatin in combination with third-generation drugs for advanced non-small cell lung cancer;Cochrane Database of Systematic Reviews;2020-01-13

3. Genetic Variants in DNA Mismatch Repair Pathway predict prognosis of Lung Cancer patients with receiving Platinum-Based Chemotherapy;Journal of Cancer;2020

4. A Novel Allosteric Inhibitor of Phosphoglycerate Mutase 1 Suppresses Growth and Metastasis of Non-Small-Cell Lung Cancer;Cell Metabolism;2019-12

5. Survival Implications of De Novo Versus Recurrent Metastatic Non–Small Cell Lung Cancer;American Journal of Clinical Oncology;2019-03